Human Chorionic Gonadotropin and Breast Cancer

Breast cancer is well known as a malignancy being strongly influenced by female steroids. Pregnancy is a protective factor against breast cancer. Human chorionic gonadotropin (HCG) is a candidate hormone which could mediate this antitumoral effect of pregnancy. For this review article, all original...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences Jg. 18; H. 7; S. 1587
Hauptverfasser: Schüler-Toprak, Susanne, Treeck, Oliver, Ortmann, Olaf
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Switzerland MDPI AG 21.07.2017
MDPI
Schlagworte:
Apoptosis
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Chorionic Gonadotropin - genetics
Chorionic Gonadotropin - metabolism
Chorionic Gonadotropin, beta Subunit, Human - genetics
Chorionic Gonadotropin, beta Subunit, Human - metabolism
Female
Genomic Imprinting
Health risk assessment
Hormone replacement therapy
Humans
Medical prognosis
Placenta - metabolism
Pregnancy
Review
Socioeconomic factors
human chorionic gonadotropin
breast cancer
pregnancy
ISSN:1422-0067, 1661-6596, 1422-0067
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Breast cancer is well known as a malignancy being strongly influenced by female steroids. Pregnancy is a protective factor against breast cancer. Human chorionic gonadotropin (HCG) is a candidate hormone which could mediate this antitumoral effect of pregnancy. For this review article, all original research articles on the role of HCG in breast cancer were considered, which are listed in PubMed database and were written in English. The role of HCG in breast cancer seems to be a paradox. Placental heterodimeric HCG acts as a protective agent by imprinting a permanent genomic signature of the mammary gland determining a refractory condition to malignant transformation which is characterized by cellular differentiation, apoptosis and growth inhibition. On the other hand, ectopic expression of β-HCG in various cancer entities is associated with poor prognosis due to its tumor-promoting function. Placental HCG and ectopically expressed β-HCG exert opposite effects on breast tumorigenesis. Therefore, mimicking pregnancy by treatment with HCG is suggested as a strategy for breast cancer prevention, whereas targeting β-HCG expressing tumor cells seems to be an option for breast cancer therapy.
AbstractList Breast cancer is well known as a malignancy being strongly influenced by female steroids. Pregnancy is a protective factor against breast cancer. Human chorionic gonadotropin (HCG) is a candidate hormone which could mediate this antitumoral effect of pregnancy. For this review article, all original research articles on the role of HCG in breast cancer were considered, which are listed in PubMed database and were written in English. The role of HCG in breast cancer seems to be a paradox. Placental heterodimeric HCG acts as a protective agent by imprinting a permanent genomic signature of the mammary gland determining a refractory condition to malignant transformation which is characterized by cellular differentiation, apoptosis and growth inhibition. On the other hand, ectopic expression of β-HCG in various cancer entities is associated with poor prognosis due to its tumor-promoting function. Placental HCG and ectopically expressed β-HCG exert opposite effects on breast tumorigenesis. Therefore, mimicking pregnancy by treatment with HCG is suggested as a strategy for breast cancer prevention, whereas targeting β-HCG expressing tumor cells seems to be an option for breast cancer therapy.Breast cancer is well known as a malignancy being strongly influenced by female steroids. Pregnancy is a protective factor against breast cancer. Human chorionic gonadotropin (HCG) is a candidate hormone which could mediate this antitumoral effect of pregnancy. For this review article, all original research articles on the role of HCG in breast cancer were considered, which are listed in PubMed database and were written in English. The role of HCG in breast cancer seems to be a paradox. Placental heterodimeric HCG acts as a protective agent by imprinting a permanent genomic signature of the mammary gland determining a refractory condition to malignant transformation which is characterized by cellular differentiation, apoptosis and growth inhibition. On the other hand, ectopic expression of β-HCG in various cancer entities is associated with poor prognosis due to its tumor-promoting function. Placental HCG and ectopically expressed β-HCG exert opposite effects on breast tumorigenesis. Therefore, mimicking pregnancy by treatment with HCG is suggested as a strategy for breast cancer prevention, whereas targeting β-HCG expressing tumor cells seems to be an option for breast cancer therapy.
Breast cancer is well known as a malignancy being strongly influenced by female steroids. Pregnancy is a protective factor against breast cancer. Human chorionic gonadotropin (HCG) is a candidate hormone which could mediate this antitumoral effect of pregnancy. For this review article, all original research articles on the role of HCG in breast cancer were considered, which are listed in PubMed database and were written in English. The role of HCG in breast cancer seems to be a paradox. Placental heterodimeric HCG acts as a protective agent by imprinting a permanent genomic signature of the mammary gland determining a refractory condition to malignant transformation which is characterized by cellular differentiation, apoptosis and growth inhibition. On the other hand, ectopic expression of β-HCG in various cancer entities is associated with poor prognosis due to its tumor-promoting function. Placental HCG and ectopically expressed β-HCG exert opposite effects on breast tumorigenesis. Therefore, mimicking pregnancy by treatment with HCG is suggested as a strategy for breast cancer prevention, whereas targeting β-HCG expressing tumor cells seems to be an option for breast cancer therapy.
Author Ortmann, Olaf
Schüler-Toprak, Susanne
Treeck, Oliver
AuthorAffiliation Department of Obstetrics and Gynecology, University Medical Center Regensburg, Caritas-Hospital St. Josef, 93053 Regensburg, Germany; sschueler@caritasstjosef.de (S.S.-T.); oortmann@caritasstjosef.de (O.O.)
AuthorAffiliation_xml – name: Department of Obstetrics and Gynecology, University Medical Center Regensburg, Caritas-Hospital St. Josef, 93053 Regensburg, Germany; sschueler@caritasstjosef.de (S.S.-T.); oortmann@caritasstjosef.de (O.O.)
Author_xml – sequence: 1
  givenname: Susanne
  surname: Schüler-Toprak
  fullname: Schüler-Toprak, Susanne
– sequence: 2
  givenname: Oliver
  orcidid: 0000-0003-2353-9693
  surname: Treeck
  fullname: Treeck, Oliver
– sequence: 3
  givenname: Olaf
  surname: Ortmann
  fullname: Ortmann, Olaf
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28754015$$D View this record in MEDLINE/PubMed
BookMark eNptkctLAzEQxoMoPqo3z7LgxYPVTB7N5iJo0SoIXvQcptmspuwmNdkV_O_d4oMqnmZgfvMx33x7ZDPE4Ag5BHrGuabnftFmKKkCWaoNsguCsTGlE7W51u-QvZwXlDLOpN4mO6xUUlCQu-Tstm8xFNOXmHwM3hazGLCKXYpLHwoMVXGVHOaumGKwLu2TrRqb7A6-6og83Vw_Tm_H9w-zu-nl_dgKYN2YVaWau6pGW0tdoqKVAI61BZgwV1KhalSIDBjjUlM1UdbpuQbupJQgkPMRufjUXfbz1lXWhS5hY5bJt5jeTURvfk-CfzHP8c1IySdUiUHg5Esgxdfe5c60PlvXNBhc7LMBzYTUWpUr9PgPuoh9CoM9w5hQSgGUMFBH6xf9nPL9ygE4_QRsijknV_8gQM0qKbOe1ICzP7j1HXZDCIMf3_y_9AHjYJV4
CitedBy_id crossref_primary_10_1080_1061186X_2024_2416247
crossref_primary_10_3389_fendo_2022_986477
crossref_primary_10_1038_s41598_023_40056_1
crossref_primary_10_3390_ijms19051502
crossref_primary_10_1007_s12262_023_03723_1
crossref_primary_10_7759_cureus_45956
crossref_primary_10_7759_cureus_88294
crossref_primary_10_1097_PGP_0000000000001102
crossref_primary_10_3390_cells10020264
crossref_primary_10_1016_j_cmpb_2024_108349
crossref_primary_10_3390_cancers10060172
crossref_primary_10_1093_jbi_wbac049
crossref_primary_10_1097_MD_0000000000040059
crossref_primary_10_15407_biotech14_03_005
crossref_primary_10_1002_kjm2_12672
crossref_primary_10_3390_s23208538
crossref_primary_10_1136_ijgc_2023_004279
crossref_primary_10_1016_j_prp_2019_01_001
crossref_primary_10_3389_fimmu_2023_1173520
crossref_primary_10_1016_j_bbcan_2020_188339
crossref_primary_10_1097_MD_0000000000028144
crossref_primary_10_3389_fpsyt_2025_1537442
crossref_primary_10_1136_jcp_2024_210002
crossref_primary_10_1007_s40664_018_0277_6
crossref_primary_10_3390_ijms25179160
crossref_primary_10_1093_carcin_bgz070
crossref_primary_10_1039_D5AN00663E
crossref_primary_10_1371_journal_pone_0295673
crossref_primary_10_1109_JLT_2023_3344755
crossref_primary_10_1007_s40664_018_0308_3
crossref_primary_10_17116_rosakush20252503127
Cites_doi 10.1371/journal.pone.0054592
10.1158/1055-9965.EPI-15-0864
10.1002/ijc.2910490409
10.1016/j.placenta.2010.06.005
10.1016/j.mce.2011.10.029
10.1186/1476-4598-7-26
10.1186/bcr3594
10.1007/BF02305802
10.1002/ijc.20323
10.1186/1471-2407-12-2
10.1007/BF01811887
10.1158/1078-0432.CCR-11-0891
10.1007/s11060-012-1017-y
10.1007/s00432-008-0458-3
10.1093/jnci/94.8.606
10.1002/cncr.2820741341
10.1210/jc.2004-2458
10.1038/bjc.1985.104
10.1016/S0140-6736(94)93054-6
10.1002/(SICI)1098-2744(199909)26:1<10::AID-MC2>3.0.CO;2-S
10.1002/1097-0142(19800101)45:1<191::AID-CNCR2820450130>3.0.CO;2-6
10.1016/0091-7435(88)90056-4
10.1016/S0021-9258(17)38469-7
10.1093/glycob/cwl034
10.1038/bjc.1996.56
10.1016/j.vaccine.2005.12.030
10.1159/000188665
10.1016/j.mce.2010.04.024
10.1158/1078-0432.CCR-03-0264
10.1172/JCI107175
10.1093/jnci/82.15.1286
10.1002/cncr.11614
10.1159/000077719
10.1016/S0140-6736(02)09454-0
10.1016/j.ctrv.2016.07.006
10.1158/0008-5472.CAN-16-1524
10.1002/bjs.1800691203
10.1074/jbc.M400683200
10.1038/sj.bjc.6600050
10.1016/j.placenta.2015.02.002
10.1210/jc.2002-021585
10.1016/S0304-3835(01)00496-7
10.1200/JCO.2006.10.3168
10.1007/s11154-011-9192-2
10.1385/MB:14:1:47
10.1002/cncr.21549
10.1002/j.1460-2075.1987.tb02449.x
10.1016/S0960-9776(03)00159-0
10.1038/485S54a
10.1002/iub.1269
10.1002/mc.22499
10.1007/978-3-540-37696-5_11
10.1136/jcp.49.4.329
10.1210/en.2007-0249
10.1210/me.2015-1187
10.1093/humrep/dei261
10.1210/endo.138.12.5618
10.1136/jcp.51.9.685
10.1016/j.cccn.2003.12.006
10.1677/jme.0.0220185
10.1002/1097-0142(19910215)67:4<869::AID-CNCR2820670402>3.0.CO;2-Q
10.3322/caac.21262
10.1093/aje/kwn254
10.1002/cncr.11294
10.1038/srep25998
10.1245/s10434-011-2104-6
10.1158/1535-7163.MCT-08-0339
10.1038/369455a0
10.1016/S0021-9258(17)44254-2
10.1002/cncr.24165
10.1373/49.7.1074
10.1002/ijc.27593
10.1093/carcin/18.9.1799
10.1159/000097703
10.1002/1097-0142(19940901)74:5<1591::AID-CNCR2820740515>3.0.CO;2-#
10.1016/j.mce.2006.06.015
10.1093/humrep/dev016
10.1016/S0022-5347(17)44088-2
10.1023/A:1005790531122
10.1210/jc.2005-2156
10.1016/j.pep.2014.10.008
10.1002/(SICI)1097-0215(19961021)69:5<369::AID-IJC3>3.0.CO;2-3
10.1002/ijc.2910360403
10.1016/0895-4356(89)90161-3
10.1007/s00428-003-0817-z
10.1186/1477-7827-8-102
10.1158/0008-5472.CAN-09-4622
10.1007/s10911-011-9228-y
10.1016/j.mce.2008.12.016
10.1002/1097-0215(20000520)89:3<293::AID-IJC13>3.0.CO;2-R
10.1186/1472-6874-14-113
10.1007/s10549-014-2852-7
10.1093/annonc/mdv379
10.1530/REP-15-0251
10.1038/bjc.1998.718
10.1038/bjc.2014.89
10.1089/bfm.2014.0141
ContentType Journal Article
Copyright 2017. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2017 by the authors. 2017
Copyright_xml – notice: 2017. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2017 by the authors. 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.3390/ijms18071587
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection (UHCL Subscription)
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Research Library (ProQuest)
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID PMC5536074
28754015
10_3390_ijms18071587
Genre Journal Article
Review
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AFFHD
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
IHR
IPNFZ
ITC
KQ8
LK8
M1P
M2O
M48
MODMG
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
TUS
UKHRP
~8M
3V.
ABJCF
ALIPV
BBNVY
BHPHI
CGR
CUY
CVF
ECM
EIF
GROUPED_DOAJ
HCIFZ
KB.
M7P
M~E
NPM
PDBOC
7XB
8FK
ESTFP
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c412t-2d87bedfacf598a70d413afc1162e8047fa7aa21223590767ce9b913e55514a33
IEDL.DBID BENPR
ISICitedReferencesCount 39
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000408746800253&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1422-0067
1661-6596
IngestDate Tue Nov 04 01:38:28 EST 2025
Thu Oct 02 07:42:41 EDT 2025
Sat Nov 29 15:01:06 EST 2025
Wed Feb 19 02:43:48 EST 2025
Tue Nov 18 21:07:10 EST 2025
Sat Nov 29 07:15:35 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords human chorionic gonadotropin
breast cancer
pregnancy
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c412t-2d87bedfacf598a70d413afc1162e8047fa7aa21223590767ce9b913e55514a33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-2353-9693
OpenAccessLink https://www.proquest.com/docview/2247771181?pq-origsite=%requestingapplication%
PMID 28754015
PQID 2247771181
PQPubID 2032341
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5536074
proquest_miscellaneous_1924599784
proquest_journals_2247771181
pubmed_primary_28754015
crossref_primary_10_3390_ijms18071587
crossref_citationtrail_10_3390_ijms18071587
PublicationCentury 2000
PublicationDate 2017-07-21
PublicationDateYYYYMMDD 2017-07-21
PublicationDate_xml – month: 07
  year: 2017
  text: 2017-07-21
  day: 21
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2017
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Cole (ref_62) 2012; 349
ref_91
Srivastava (ref_74) 1997; 18
Hudelist (ref_55) 2009; 135
Zhou (ref_39) 2015; 10
Cole (ref_65) 2010; 31
Reeves (ref_32) 2000; 89
Sun (ref_21) 2016; 25
Korzeniowski (ref_11) 1994; 74
Hotakainen (ref_92) 2002; 86
Wang (ref_19) 1985; 36
Giovangrandi (ref_60) 2001; 168
Casarini (ref_57) 2015; 150
Srivastava (ref_73) 1999; 26
Reed (ref_26) 2003; 443
Bernstein (ref_80) 1995; 4
Butler (ref_71) 2003; 9
Islami (ref_41) 2015; 26
Toniolo (ref_76) 2010; 70
Sutton (ref_63) 2004; 341
Palmer (ref_14) 1982; 69
Fortner (ref_78) 2017; 77
Liao (ref_82) 2014; 66
Grosser (ref_10) 1988; 17
Papatestas (ref_12) 1980; 45
Schouten (ref_17) 1997; 43
Fournier (ref_42) 2015; 36
Casarini (ref_56) 2011; 12
Lukanova (ref_77) 2008; 168
Meduri (ref_54) 2003; 97
Hamada (ref_100) 2005; 90
Crawford (ref_93) 1998; 51
Butler (ref_95) 1999; 22
Daling (ref_31) 2002; 11
Piersma (ref_58) 2006; 91
Valmu (ref_68) 2006; 16
Guinee (ref_22) 1994; 343
Gillott (ref_69) 1996; 73
Fiddes (ref_50) 1984; 40
Srivastava (ref_86) 1998; 18
Ewertz (ref_16) 1991; 49
McCready (ref_23) 2014; 16
Hotakainen (ref_61) 2007; 28
Greenberg (ref_15) 1985; 51
Li (ref_83) 2004; 279
Torre (ref_1) 2015; 65
Lapthorn (ref_96) 1994; 369
Nagirnaja (ref_44) 2010; 329
Cole (ref_64) 2010; 8
Middleton (ref_24) 2003; 98
Russo (ref_81) 2007; 174
Edwards (ref_99) 1987; 6
Bellet (ref_43) 1997; 57
Li (ref_103) 2013; 111
Black (ref_9) 1983; 70
Nand (ref_47) 2015; 106
Koistinen (ref_97) 2015; 29
Russo (ref_75) 2011; 16
Mason (ref_13) 1990; 15
Petrek (ref_28) 1991; 67
MacMahon (ref_7) 1970; 43
Reimer (ref_45) 2000; 14
Kroman (ref_8) 2003; 12
Powell (ref_59) 2003; 88
Butler (ref_46) 2004; 25
LaBenz (ref_51) 1997; 138
Kuijper (ref_53) 2009; 302
Taback (ref_106) 2001; 61
Wang (ref_4) 2016; 6
Jankowska (ref_98) 2008; 7
Rull (ref_52) 2005; 20
Lopez (ref_87) 2008; 7
Wurzel (ref_88) 1987; 137
Span (ref_107) 2003; 49
Vyas (ref_113) 2009; 76
Evans (ref_66) 2015; 30
Janssens (ref_79) 2007; 269
Policastro (ref_48) 1986; 261
Anderson (ref_25) 1996; 3
Barnett (ref_35) 2008; 26
Sheaff (ref_89) 1996; 49
Yuri (ref_84) 2014; 34
Khare (ref_104) 2017; 56
Morse (ref_112) 2011; 17
He (ref_111) 2004; 10
ref_34
Agrawal (ref_5) 1995; 55
Beadle (ref_30) 2009; 115
Douglas (ref_94) 2014; 110
McGuire (ref_2) 1973; 52
Layde (ref_37) 1989; 42
Policastro (ref_49) 1983; 258
Lambertini (ref_40) 2016; 49
Wu (ref_101) 2006; 106
Moulton (ref_110) 2002; 8
Kroman (ref_18) 1998; 78
ref_38
Petrek (ref_29) 1994; 74
Butler (ref_70) 2000; 82
Pilewskie (ref_27) 2012; 19
Cole (ref_67) 2006; 51
Eisenstein (ref_6) 2012; 485
Anderson (ref_36) 2014; 144
Lundin (ref_90) 2000; 20
Rosenberg (ref_33) 2004; 111
Guo (ref_85) 2004; 24
Key (ref_3) 2002; 94
Russo (ref_72) 1990; 82
Yi (ref_109) 2006; 24
ref_102
Hoon (ref_105) 1996; 69
Alsaker (ref_20) 2013; 132
Kuorelahti (ref_108) 2007; 148
25785349 - Breastfeed Med. 2015 Apr;10(3):175-82
20735820 - Reprod Biol Endocrinol. 2010 Aug 24;8:102
27184120 - Sci Rep. 2016 May 17;6:25998
18936438 - Am J Epidemiol. 2008 Dec 1;168(11):1284-91
17165440 - J Reprod Med. 2006 Nov;51(11):919-29
10911614 - Mol Biotechnol. 2000 Jan;14 (1):47-57
21632857 - Clin Cancer Res. 2011 Jul 15;17(14):4844-53
10487517 - Mol Carcinog. 1999 Sep;26(1):10-9
15886246 - J Clin Endocrinol Metab. 2005 Aug;90(8):4873-9
12679452 - J Clin Endocrinol Metab. 2003 Apr;88(4):1653-7
26504151 - Ann Oncol. 2015 Dec;26(12 ):2398-407
27784743 - Cancer Res. 2017 Jan 1;77(1):134-141
18339208 - Mol Cancer. 2008 Mar 14;7:26
12114402 - Clin Cancer Res. 2002 Jul;8(7):2044-51
25707740 - Placenta. 2015 Apr;36 Suppl 1:S60-5
7171968 - Br J Surg. 1982 Dec;69(12):697-8
10789723 - Br J Cancer. 2000 May;82(9):1553-6
18790764 - Mol Cancer Ther. 2008 Sep;7(9):2837-44
17386970 - Mol Cell Endocrinol. 2007 Apr 15;269(1-2):93-8
16464948 - J Clin Endocrinol Metab. 2006 Apr;91(4):1470-6
11368883 - Cancer Lett. 2001 Jul 10;168(1):93-100
14967177 - Clin Chim Acta. 2004 Mar;341(1-2):199-203
27152491 - Mol Carcinog. 2017 Feb;56(2):359-370
24405573 - Breast Cancer Res. 2014 Jan 09;16(1):R2
9012484 - Cancer Res. 1997 Feb 1;57(3):516-23
6207567 - Recent Prog Horm Res. 1984;40:43-78
27529149 - Cancer Treat Rev. 2016 Sep;49:65-76
6571917 - J Natl Cancer Inst. 1983 Jan;70(1):27-30
2422163 - J Biol Chem. 1986 May 5;261(13):5907-16
8646523 - Ann Surg Oncol. 1996 Mar;3(2):204-11
21805333 - J Mammary Gland Biol Neoplasia. 2011 Sep;16(3):221-33
11751407 - Cancer Res. 2001 Dec 15;61(24):8845-50
7351001 - Cancer. 1980 Jan 1;45(1):191-4
22101319 - Mol Cell Endocrinol. 2012 Feb 26;349(2):232-8
11895871 - Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):235-41
2820711 - EMBO J. 1987 Jul;6(7):1899-904
10861507 - Int J Cancer. 2000 May 20;89(3):293-9
16323172 - Cancer. 2006 Jan 1;106(1):68-78
3994912 - Br J Cancer. 1985 May;51(5):691-7
2115592 - J Natl Cancer Inst. 1990 Aug 1;82(15):1286-9
6194155 - J Biol Chem. 1983 Oct 10;258(19):11492-9
9836489 - Br J Cancer. 1998 Dec;78(11):1529-33
24477977 - Breast Cancer Res Treat. 2014 Feb;144(1):1-10
23232806 - J Neurooncol. 2013 Feb;111(3):237-44
3820387 - J Urol. 1987 Mar;137(3):502-4
26370242 - Reproduction. 2015 Dec;150(6):R175-84
15252849 - Int J Cancer. 2004 Sep 20;111(5):772-6
24556622 - Br J Cancer. 2014 Apr 2;110(7):1759-66
8562337 - Br J Cancer. 1996 Feb;73(3):323-6
4345203 - J Clin Invest. 1973 Jan;52(1):73-7
1917153 - Int J Cancer. 1991 Oct 21;49(4):526-30
7911917 - Lancet. 1994 Jun 25;343(8913):1587-9
9891438 - Anticancer Res. 1998 Nov-Dec;18(6A):4003-10
12816903 - Clin Chem. 2003 Jul;49(7):1074-80
22511284 - Int J Cancer. 2013 Jan 1;132(1):174-81
22214378 - BMC Cancer. 2012 Jan 03;12:2
21912887 - Rev Endocr Metab Disord. 2011 Dec;12(4):303-21
2681548 - J Clin Epidemiol. 1989;42(10):963-73
18612147 - J Clin Oncol. 2008 Jul 10;26(20):3310-6
15041707 - Clin Cancer Res. 2004 Mar 15;10(6):1920-7
7538899 - Cancer Res. 1995 Jun 1;55(11):2257-61
11959894 - J Natl Cancer Inst. 2002 Apr 17;94(8):606-16
12133652 - Lancet. 2002 Jul 20;360(9328):187-95
19356624 - Mol Cell Endocrinol. 2009 Apr 10;302(1):58-64
25231360 - BMC Womens Health. 2014 Sep 18;14:113
24596382 - Anticancer Res. 2014 Mar;34(3):1347-54
26495869 - Mol Endocrinol. 2015 Dec;29(12):1787-91
9328178 - Carcinogenesis. 1997 Sep;18(9):1799-808
12942575 - Cancer. 2003 Sep 1;98(5):1055-60
14581335 - Clin Cancer Res. 2003 Oct 15;9(13):4666-73
7549796 - Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):437-40
3237661 - Prev Med. 1988 Sep;17(5):634-42
1991259 - Cancer. 1991 Feb 15;67(4):869-72
19127081 - Oncology. 2009;76(2):101-11
26545404 - Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):60-7
25651787 - CA Cancer J Clin. 2015 Mar;65(2):87-108
17302191 - Recent Results Cancer Res. 2007;174:111-30
24753159 - IUBMB Life. 2014 May;66(5):352-60
5312521 - Bull World Health Organ. 1970;43(2):209-21
11870503 - Br J Cancer. 2002 Jan 21;86(2):185-9
15192308 - Tumour Biol. 2004 Jan-Apr;25(1-2):18-23
20488225 - Mol Cell Endocrinol. 2010 Nov 25;329(1-2):4-16
17510243 - Endocrinology. 2007 Aug;148(8):3694-703
16123088 - Hum Reprod. 2005 Dec;20(12):3360-8
4044053 - Int J Cancer. 1985 Oct 15;36(4):427-32
14659129 - Breast. 2003 Dec;12(6):516-21
9930074 - J Clin Pathol. 1998 Sep;51(9):685-8
16880503 - Glycobiology. 2006 Dec;16(12):1207-18
2328328 - Breast Cancer Res Treat. 1990 Jan;15(1):27-37
9150901 - Breast Cancer Res Treat. 1997 May;43(3):217-23
11326644 - Anticancer Res. 2000 Nov-Dec;20(6D):4949-51
25448825 - Protein Expr Purif. 2015 Feb;106:10-7
12655539 - Cancer. 2003 Apr 1;97(7):1810-6
14719117 - Int J Oncol. 2004 Feb;24(2):399-407
17139196 - Tumour Biol. 2007;28(1):52-6
8062190 - Cancer. 1994 Sep 1;74(5):1591-4
20619452 - Placenta. 2010 Aug;31(8):653-64
23424616 - PLoS One. 2013;8(2):e54592
8004627 - Cancer. 1994 Jul 1;74(1 Suppl):518-27
21997350 - Ann Surg Oncol. 2012 Apr;19(4):1167-73
19204903 - Cancer. 2009 Mar 15;115(6):1174-84
25743784 - Hum Reprod. 2015 May;30(5):1029-38
9389532 - Endocrinology. 1997 Dec;138(12):5459-65
22648499 - Nature. 2012 May 30;485(7400):S54
18758818 - J Cancer Res Clin Oncol. 2009 Feb;135(2):191-5
8655711 - J Clin Pathol. 1996 Apr;49(4):329-32
8202136 - Nature. 1994 Jun 9;369(6480):455-61
20713523 - Cancer Res. 2010 Sep 1;70(17):6779-86
15044447 - J Biol Chem. 2004 Jun 11;279(24):25503-10
16420967 - Vaccine. 2006 Mar 24;24(14):2575-84
8900369 - Int J Cancer. 1996 Oct 21;69(5):369-74
10194521 - J Mol Endocrinol. 1999 Apr;22(2):185-92
12756565 - Virchows Arch. 2003 Jul;443(1):44-50
References_xml – ident: ref_102
  doi: 10.1371/journal.pone.0054592
– volume: 25
  start-page: 60
  year: 2016
  ident: ref_21
  article-title: Association of parity and time since last birth with breast cancer prognosis by intrinsic subtype
  publication-title: Cancer Epidemiol. Biomark. Prev.
  doi: 10.1158/1055-9965.EPI-15-0864
– volume: 49
  start-page: 526
  year: 1991
  ident: ref_16
  article-title: Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.2910490409
– volume: 31
  start-page: 653
  year: 2010
  ident: ref_65
  article-title: Hyperglycosylated HCG, a review
  publication-title: Placenta
  doi: 10.1016/j.placenta.2010.06.005
– volume: 349
  start-page: 232
  year: 2012
  ident: ref_62
  article-title: Hyperglycosylated HCG, HCGβ and hyperglycosylated HCGβ: Interchangeable cancer promoters
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2011.10.029
– volume: 7
  start-page: 26
  year: 2008
  ident: ref_98
  article-title: Reduction of human chorionic gonadotropin β subunit expression by modified U1 snRNA caused apoptosis in cervical cancer cells
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-7-26
– volume: 16
  start-page: R2
  year: 2014
  ident: ref_23
  article-title: Pregnancy-associated breast cancers are driven by differences in adipose stromal cells present during lactation
  publication-title: Breast Cancer Res.
  doi: 10.1186/bcr3594
– volume: 3
  start-page: 204
  year: 1996
  ident: ref_25
  article-title: Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger
  publication-title: Ann. Surg. Oncol.
  doi: 10.1007/BF02305802
– volume: 111
  start-page: 772
  year: 2004
  ident: ref_33
  article-title: Childbirth and breast cancer prognosis
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.20323
– ident: ref_91
  doi: 10.1186/1471-2407-12-2
– volume: 15
  start-page: 27
  year: 1990
  ident: ref_13
  article-title: Season of tumour detection influences factors predicting survival of patients with breast cancer
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/BF01811887
– volume: 17
  start-page: 4844
  year: 2011
  ident: ref_112
  article-title: Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-11-0891
– volume: 111
  start-page: 237
  year: 2013
  ident: ref_103
  article-title: Human chorionic gonadotropin β induces cell motility via ERK1/2 and MMP-2 activation in human glioblastoma U87MG cells
  publication-title: J. Neurooncol.
  doi: 10.1007/s11060-012-1017-y
– volume: 135
  start-page: 191
  year: 2009
  ident: ref_55
  article-title: Β-HCG/lh receptor (b-HCG/LH-R) expression is increased in invasive versus preinvasive breast cancer: Implications for breast carcinogenesis?
  publication-title: J. Cancer Res. Clin. Oncol.
  doi: 10.1007/s00432-008-0458-3
– volume: 94
  start-page: 606
  year: 2002
  ident: ref_3
  article-title: Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/94.8.606
– volume: 74
  start-page: 518
  year: 1994
  ident: ref_29
  article-title: Breast cancer during pregnancy
  publication-title: Cancer
  doi: 10.1002/cncr.2820741341
– volume: 90
  start-page: 4873
  year: 2005
  ident: ref_100
  article-title: Transfection of antisense chorionic gonadotropin β gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2004-2458
– volume: 51
  start-page: 691
  year: 1985
  ident: ref_15
  article-title: Body size and survival in premenopausal breast cancer
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.1985.104
– volume: 343
  start-page: 1587
  year: 1994
  ident: ref_22
  article-title: Effect of pregnancy on prognosis for young women with breast cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(94)93054-6
– volume: 26
  start-page: 10
  year: 1999
  ident: ref_73
  article-title: Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin associated with increased expression of inhibin
  publication-title: Mol. Carcinog.
  doi: 10.1002/(SICI)1098-2744(199909)26:1<10::AID-MC2>3.0.CO;2-S
– volume: 45
  start-page: 191
  year: 1980
  ident: ref_12
  article-title: Parity and prognosis in breast cancer
  publication-title: Cancer
  doi: 10.1002/1097-0142(19800101)45:1<191::AID-CNCR2820450130>3.0.CO;2-6
– volume: 20
  start-page: 4949
  year: 2000
  ident: ref_90
  article-title: A comparison of serum and tissue HCG β as prognostic markers in colorectal cancer
  publication-title: Anticancer Res.
– volume: 17
  start-page: 634
  year: 1988
  ident: ref_10
  article-title: Body size, reproductive factors, and breast cancer survival
  publication-title: Prev. Med.
  doi: 10.1016/0091-7435(88)90056-4
– volume: 261
  start-page: 5907
  year: 1986
  ident: ref_48
  article-title: A map of the HCG β-lh β gene cluster
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(17)38469-7
– volume: 16
  start-page: 1207
  year: 2006
  ident: ref_68
  article-title: Site-specific glycan analysis of human chorionic gonadotropin β-subunit from malignancies and pregnancy by liquid chromatography—Electrospray mass spectrometry
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwl034
– volume: 73
  start-page: 323
  year: 1996
  ident: ref_69
  article-title: The effects of β-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.1996.56
– volume: 24
  start-page: 2575
  year: 2006
  ident: ref_109
  article-title: Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat β-HCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.12.030
– volume: 76
  start-page: 101
  year: 2009
  ident: ref_113
  article-title: Selective killing of leukemia and lymphoma cells ectopically expressing HCGβ by a conjugate of curcumin with an antibody against HCGβ subunit
  publication-title: Oncology
  doi: 10.1159/000188665
– volume: 329
  start-page: 4
  year: 2010
  ident: ref_44
  article-title: Genomics and genetics of gonadotropin β-subunit genes: Unique FSHB and duplicated LHB/CGB loci
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2010.04.024
– volume: 10
  start-page: 1920
  year: 2004
  ident: ref_111
  article-title: A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin β
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-03-0264
– volume: 52
  start-page: 73
  year: 1973
  ident: ref_2
  article-title: Estrogen receptors in human breast cancer
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI107175
– volume: 82
  start-page: 1286
  year: 1990
  ident: ref_72
  article-title: Human chorionic gonadotropin and rat mammary cancer prevention
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/82.15.1286
– volume: 98
  start-page: 1055
  year: 2003
  ident: ref_24
  article-title: Breast carcinoma in pregnant women: Assessment of clinicopathologic and immunohistochemical features
  publication-title: Cancer
  doi: 10.1002/cncr.11614
– volume: 25
  start-page: 18
  year: 2004
  ident: ref_46
  article-title: The free monomeric β subunit of human chorionic gonadotrophin (HCG β) and the recently identified homodimeric β-β subunit (HCG β β) both have autocrine growth effects
  publication-title: Tumour Biol.
  doi: 10.1159/000077719
– ident: ref_38
  doi: 10.1016/S0140-6736(02)09454-0
– volume: 49
  start-page: 65
  year: 2016
  ident: ref_40
  article-title: Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies
  publication-title: Cancer Treat. Rev.
  doi: 10.1016/j.ctrv.2016.07.006
– volume: 77
  start-page: 134
  year: 2017
  ident: ref_78
  article-title: Human chorionic gonadotropin does not correlate with risk for maternal breast cancer: Results from the Finnish maternity cohort
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-16-1524
– volume: 69
  start-page: 697
  year: 1982
  ident: ref_14
  article-title: Prognostic factors in breast cancer
  publication-title: Br. J. Surg.
  doi: 10.1002/bjs.1800691203
– volume: 279
  start-page: 25503
  year: 2004
  ident: ref_83
  article-title: Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-κB and AP-1 activation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M400683200
– volume: 86
  start-page: 185
  year: 2002
  ident: ref_92
  article-title: The free β-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6600050
– volume: 36
  start-page: S60
  year: 2015
  ident: ref_42
  article-title: Review: HCGs: Different sources of production, different glycoforms and functions
  publication-title: Placenta
  doi: 10.1016/j.placenta.2015.02.002
– volume: 88
  start-page: 1653
  year: 2003
  ident: ref_59
  article-title: Luteinizing hormone signaling and breast cancer: Polymorphisms and age of onset
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2002-021585
– volume: 168
  start-page: 93
  year: 2001
  ident: ref_60
  article-title: Analysis of the human CGB/LHB gene cluster in breast tumors by real-time quantitative RT-PCR assays
  publication-title: Cancer Lett.
  doi: 10.1016/S0304-3835(01)00496-7
– volume: 26
  start-page: 3310
  year: 2008
  ident: ref_35
  article-title: Risk factors for the incidence of breast cancer: Do they affect survival from the disease?
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2006.10.3168
– volume: 24
  start-page: 399
  year: 2004
  ident: ref_85
  article-title: Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells
  publication-title: Int. J. Oncol.
– volume: 12
  start-page: 303
  year: 2011
  ident: ref_56
  article-title: Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function
  publication-title: Rev. Endocr. Metab. Disord.
  doi: 10.1007/s11154-011-9192-2
– volume: 14
  start-page: 47
  year: 2000
  ident: ref_45
  article-title: Absolute quantification of human chorionic gonadotropin-β mRNA with TaqMan detection 4
  publication-title: Mol. Biotechnol.
  doi: 10.1385/MB:14:1:47
– volume: 70
  start-page: 27
  year: 1983
  ident: ref_9
  article-title: Parity as a prognostic factor in young breast cancer patients
  publication-title: J. Natl. Cancer Inst.
– volume: 106
  start-page: 68
  year: 2006
  ident: ref_101
  article-title: Human chorionic gonadotropin β (HCGβ) down-regulates E-cadherin and promotes human prostate carcinoma cell migration and invasion
  publication-title: Cancer
  doi: 10.1002/cncr.21549
– volume: 6
  start-page: 1899
  year: 1987
  ident: ref_99
  article-title: Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1987.tb02449.x
– volume: 12
  start-page: 516
  year: 2003
  ident: ref_8
  article-title: Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer
  publication-title: Breast
  doi: 10.1016/S0960-9776(03)00159-0
– volume: 485
  start-page: S54
  year: 2012
  ident: ref_6
  article-title: Pregnancy: Delivery from breast cancer
  publication-title: Nature
  doi: 10.1038/485S54a
– volume: 40
  start-page: 43
  year: 1984
  ident: ref_50
  article-title: Structure, expression, and evolution of the genes for the human glycoprotein hormones
  publication-title: Recent Prog. Horm. Res.
– volume: 4
  start-page: 437
  year: 1995
  ident: ref_80
  article-title: Treatment with human chorionic gonadotropin and risk of breast cancer
  publication-title: Cancer Epidemiol. Biomark. Prev.
– volume: 66
  start-page: 352
  year: 2014
  ident: ref_82
  article-title: Human chorionic gonadotropin decreases human breast cancer cell proliferation and promotes differentiation
  publication-title: IUBMB Life
  doi: 10.1002/iub.1269
– volume: 56
  start-page: 359
  year: 2017
  ident: ref_104
  article-title: Gonadotropin and tumorigenesis: Direct and indirect effects on inflammatory and immunosuppressive mediators and invasion
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.22499
– volume: 174
  start-page: 111
  year: 2007
  ident: ref_81
  article-title: Primary prevention of breast cancer by hormone-induced differentiation
  publication-title: Recent Res. Cancer Res.
  doi: 10.1007/978-3-540-37696-5_11
– volume: 49
  start-page: 329
  year: 1996
  ident: ref_89
  article-title: β HCG as a prognostic marker in adenocarcinoma of the prostate
  publication-title: J. Clin. Pathol.
  doi: 10.1136/jcp.49.4.329
– volume: 148
  start-page: 3694
  year: 2007
  ident: ref_108
  article-title: Human chorionic gonadotropin (HCG) up-regulates Wnt5b and Wnt7b in the mammary gland, and HCGβ transgenic female mice present with mammary gland tumors exhibiting characteristics of the Wnt/β-catenin pathway activation
  publication-title: Endocrinology
  doi: 10.1210/en.2007-0249
– volume: 29
  start-page: 1787
  year: 2015
  ident: ref_97
  article-title: Absence of TGF-β receptor activation by highly purified HCG preparations
  publication-title: Mol. Endocrinol.
  doi: 10.1210/me.2015-1187
– volume: 20
  start-page: 3360
  year: 2005
  ident: ref_52
  article-title: Expression of β-subunit of HCG genes during normal and failed pregnancy
  publication-title: Hum. Reprod.
  doi: 10.1093/humrep/dei261
– volume: 51
  start-page: 919
  year: 2006
  ident: ref_67
  article-title: Hyperglycosylated HCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis
  publication-title: J. Reprod. Med.
– volume: 138
  start-page: 5459
  year: 1997
  ident: ref_51
  article-title: Human chorionic gonadotropin-β gene expression in first trimester placenta
  publication-title: Endocrinology
  doi: 10.1210/endo.138.12.5618
– volume: 18
  start-page: 4003
  year: 1998
  ident: ref_86
  article-title: Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells
  publication-title: Anticancer Res.
– volume: 51
  start-page: 685
  year: 1998
  ident: ref_93
  article-title: The prognostic significance of β human chorionic gonadotrophin and its metabolites in women with cervical carcinoma
  publication-title: J. Clin. Pathol.
  doi: 10.1136/jcp.51.9.685
– volume: 341
  start-page: 199
  year: 2004
  ident: ref_63
  article-title: Charge variants in serum and urine HCG
  publication-title: Clin. Chim. Acta Int. J. Clin. Chem.
  doi: 10.1016/j.cccn.2003.12.006
– volume: 22
  start-page: 185
  year: 1999
  ident: ref_95
  article-title: The β-subunit of human chorionic gonadotrophin exists as a homodimer
  publication-title: J. Mol. Endocrinol.
  doi: 10.1677/jme.0.0220185
– volume: 67
  start-page: 869
  year: 1991
  ident: ref_28
  article-title: Prognosis of pregnancy-associated breast cancer
  publication-title: Cancer
  doi: 10.1002/1097-0142(19910215)67:4<869::AID-CNCR2820670402>3.0.CO;2-Q
– volume: 65
  start-page: 87
  year: 2015
  ident: ref_1
  article-title: Global cancer statistics, 2012
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21262
– volume: 168
  start-page: 1284
  year: 2008
  ident: ref_77
  article-title: Human chorionic gonadotropin and α-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: A nested case-control study
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/aje/kwn254
– volume: 97
  start-page: 1810
  year: 2003
  ident: ref_54
  article-title: Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomas
  publication-title: Cancer
  doi: 10.1002/cncr.11294
– volume: 6
  start-page: 25998
  year: 2016
  ident: ref_4
  article-title: Plasma prolactin and breast cancer risk: A meta-analysis
  publication-title: Sci. Rep.
  doi: 10.1038/srep25998
– volume: 19
  start-page: 1167
  year: 2012
  ident: ref_27
  article-title: Association between recency of last pregnancy and biologic subtype of breast cancer
  publication-title: Ann. Surg. Oncol.
  doi: 10.1245/s10434-011-2104-6
– volume: 7
  start-page: 2837
  year: 2008
  ident: ref_87
  article-title: Purified human chorionic gonadotropin induces apoptosis in breast cancer
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-08-0339
– volume: 369
  start-page: 455
  year: 1994
  ident: ref_96
  article-title: Crystal structure of human chorionic gonadotropin
  publication-title: Nature
  doi: 10.1038/369455a0
– volume: 258
  start-page: 11492
  year: 1983
  ident: ref_49
  article-title: The β subunit of human chorionic gonadotropin is encoded by multiple genes
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(17)44254-2
– volume: 11
  start-page: 235
  year: 2002
  ident: ref_31
  article-title: The relation of reproductive factors to mortality from breast cancer
  publication-title: Cancer Epidemiol. Biomark. Prev.
– volume: 115
  start-page: 1174
  year: 2009
  ident: ref_30
  article-title: The impact of pregnancy on breast cancer outcomes in women < or = 35 years
  publication-title: Cancer
  doi: 10.1002/cncr.24165
– volume: 49
  start-page: 1074
  year: 2003
  ident: ref_107
  article-title: Molecular beacon reverse transcription-PCR of human chorionic gonadotropin-β-3, -5, and -8 mRNAs has prognostic value in breast cancer
  publication-title: Clin. Chem.
  doi: 10.1373/49.7.1074
– volume: 132
  start-page: 174
  year: 2013
  ident: ref_20
  article-title: Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: A register-based study from Norway
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.27593
– volume: 18
  start-page: 1799
  year: 1997
  ident: ref_74
  article-title: Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/18.9.1799
– volume: 28
  start-page: 52
  year: 2007
  ident: ref_61
  article-title: Overexpression of human chorionic gonadotropin β genes 3, 5 and 8 in tumor tissue and urinary cells of bladder cancer patients
  publication-title: Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med.
  doi: 10.1159/000097703
– volume: 74
  start-page: 1591
  year: 1994
  ident: ref_11
  article-title: Reproductive history and prognosis in patients with operable breast cancer
  publication-title: Cancer
  doi: 10.1002/1097-0142(19940901)74:5<1591::AID-CNCR2820740515>3.0.CO;2-#
– volume: 57
  start-page: 516
  year: 1997
  ident: ref_43
  article-title: Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin β genes normally transcribed in trophoblastic cells
  publication-title: Cancer Res.
– volume: 269
  start-page: 93
  year: 2007
  ident: ref_79
  article-title: Human chorionic gonadotropin (HCG) and prevention of breast cancer
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2006.06.015
– volume: 30
  start-page: 1029
  year: 2015
  ident: ref_66
  article-title: Dynamic changes in hyperglycosylated human chorionic gonadotrophin throughout the first trimester of pregnancy and its role in early placentation
  publication-title: Hum. Reprod.
  doi: 10.1093/humrep/dev016
– volume: 137
  start-page: 502
  year: 1987
  ident: ref_88
  article-title: Ectopic production of human chorionic gonadotropin by poorly differentiated transitional cell tumors of the urinary tract
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)44088-2
– volume: 8
  start-page: 2044
  year: 2002
  ident: ref_110
  article-title: Active specific immunotherapy with a β-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: Antibody response is associated with improved survival
  publication-title: Clin. Cancer Res.
– volume: 43
  start-page: 217
  year: 1997
  ident: ref_17
  article-title: Prognostic significance of etiological risk factors in early breast cancer
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1023/A:1005790531122
– volume: 91
  start-page: 1470
  year: 2006
  ident: ref_58
  article-title: A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2005-2156
– volume: 106
  start-page: 10
  year: 2015
  ident: ref_47
  article-title: Development of a recombinant HCG-specific single chain immunotoxin cytotoxic to HCG expressing cancer cells
  publication-title: Protein Expr. Purif.
  doi: 10.1016/j.pep.2014.10.008
– volume: 9
  start-page: 4666
  year: 2003
  ident: ref_71
  article-title: Ectopic human chorionic gonadotropin β secretion by epithelial tumors and human chorionic gonadotropin β-induced apoptosis in Kaposi’s sarcoma: Is there a connection?
  publication-title: Clin. Cancer Res.
– volume: 69
  start-page: 369
  year: 1996
  ident: ref_105
  article-title: Detection of metastatic breast cancer by β-HCG polymerase chain reaction
  publication-title: Int. J. Cancer
  doi: 10.1002/(SICI)1097-0215(19961021)69:5<369::AID-IJC3>3.0.CO;2-3
– volume: 55
  start-page: 2257
  year: 1995
  ident: ref_5
  article-title: Does pregnancy immunize against breast cancer?
  publication-title: Cancer Res.
– volume: 36
  start-page: 427
  year: 1985
  ident: ref_19
  article-title: Influence of reproductive history on age at diagnosis of breast cancer and prognosis
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.2910360403
– volume: 42
  start-page: 963
  year: 1989
  ident: ref_37
  article-title: The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and steroid hormone study group
  publication-title: J. Clin. Epidemiol.
  doi: 10.1016/0895-4356(89)90161-3
– volume: 443
  start-page: 44
  year: 2003
  ident: ref_26
  article-title: Pregnancy and breast cancer: A population-based study
  publication-title: Virchows Arch.
  doi: 10.1007/s00428-003-0817-z
– volume: 8
  start-page: 102
  year: 2010
  ident: ref_64
  article-title: Biological functions of HCG and HCG-related molecules
  publication-title: Reprod. Biol. Endocrinol.
  doi: 10.1186/1477-7827-8-102
– volume: 70
  start-page: 6779
  year: 2010
  ident: ref_76
  article-title: Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-4622
– volume: 82
  start-page: 1553
  year: 2000
  ident: ref_70
  article-title: The increase in bladder carcinoma cell population induced by the free β subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation
  publication-title: Br. J. Cancer
– volume: 16
  start-page: 221
  year: 2011
  ident: ref_75
  article-title: Pregnancy-induced changes in breast cancer risk
  publication-title: J. Mammary Gland Biol. Neoplasia
  doi: 10.1007/s10911-011-9228-y
– volume: 61
  start-page: 8845
  year: 2001
  ident: ref_106
  article-title: Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: Correlation with clinical stage of disease
  publication-title: Cancer Res.
– volume: 34
  start-page: 1347
  year: 2014
  ident: ref_84
  article-title: Human chorionic gonadotropin suppresses human breast cancer cell growth directly via p53-mediated mitochondrial apoptotic pathway and indirectly via ovarian steroid secretion
  publication-title: Anticancer Res.
– volume: 302
  start-page: 58
  year: 2009
  ident: ref_53
  article-title: Lh receptor gene expression is essentially absent in breast tumor tissue: Implications for treatment
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2008.12.016
– volume: 89
  start-page: 293
  year: 2000
  ident: ref_32
  article-title: Hormonal and other factors in relation to survival among breast cancer patients
  publication-title: Int. J. Cancer
  doi: 10.1002/1097-0215(20000520)89:3<293::AID-IJC13>3.0.CO;2-R
– volume: 43
  start-page: 209
  year: 1970
  ident: ref_7
  article-title: Age at first birth and breast cancer risk
  publication-title: Bull. World Health Organ.
– ident: ref_34
  doi: 10.1186/1472-6874-14-113
– volume: 144
  start-page: 1
  year: 2014
  ident: ref_36
  article-title: Reproductive risk factors and breast cancer subtypes: A review of the literature
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-014-2852-7
– volume: 26
  start-page: 2398
  year: 2015
  ident: ref_41
  article-title: Breastfeeding and breast cancer risk by receptor status—A systematic review and meta-analysis
  publication-title: Ann. Oncol.
  doi: 10.1093/annonc/mdv379
– volume: 150
  start-page: R175
  year: 2015
  ident: ref_57
  article-title: Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success
  publication-title: Reproduction
  doi: 10.1530/REP-15-0251
– volume: 78
  start-page: 1529
  year: 1998
  ident: ref_18
  article-title: Parity, age at first childbirth and the prognosis of primary breast cancer
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.1998.718
– volume: 110
  start-page: 1759
  year: 2014
  ident: ref_94
  article-title: Serum total HCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.2014.89
– volume: 10
  start-page: 175
  year: 2015
  ident: ref_39
  article-title: Association between breastfeeding and breast cancer risk: Evidence from a meta-analysis
  publication-title: Breastfeed Med.
  doi: 10.1089/bfm.2014.0141
– reference: 20488225 - Mol Cell Endocrinol. 2010 Nov 25;329(1-2):4-16
– reference: 24477977 - Breast Cancer Res Treat. 2014 Feb;144(1):1-10
– reference: 14719117 - Int J Oncol. 2004 Feb;24(2):399-407
– reference: 10194521 - J Mol Endocrinol. 1999 Apr;22(2):185-92
– reference: 8202136 - Nature. 1994 Jun 9;369(6480):455-61
– reference: 12655539 - Cancer. 2003 Apr 1;97(7):1810-6
– reference: 7171968 - Br J Surg. 1982 Dec;69(12):697-8
– reference: 3820387 - J Urol. 1987 Mar;137(3):502-4
– reference: 9836489 - Br J Cancer. 1998 Dec;78(11):1529-33
– reference: 26370242 - Reproduction. 2015 Dec;150(6):R175-84
– reference: 1991259 - Cancer. 1991 Feb 15;67(4):869-72
– reference: 17386970 - Mol Cell Endocrinol. 2007 Apr 15;269(1-2):93-8
– reference: 9930074 - J Clin Pathol. 1998 Sep;51(9):685-8
– reference: 21912887 - Rev Endocr Metab Disord. 2011 Dec;12(4):303-21
– reference: 2115592 - J Natl Cancer Inst. 1990 Aug 1;82(15):1286-9
– reference: 22101319 - Mol Cell Endocrinol. 2012 Feb 26;349(2):232-8
– reference: 4345203 - J Clin Invest. 1973 Jan;52(1):73-7
– reference: 6207567 - Recent Prog Horm Res. 1984;40:43-78
– reference: 12133652 - Lancet. 2002 Jul 20;360(9328):187-95
– reference: 7549796 - Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):437-40
– reference: 20619452 - Placenta. 2010 Aug;31(8):653-64
– reference: 16323172 - Cancer. 2006 Jan 1;106(1):68-78
– reference: 19356624 - Mol Cell Endocrinol. 2009 Apr 10;302(1):58-64
– reference: 14581335 - Clin Cancer Res. 2003 Oct 15;9(13):4666-73
– reference: 15041707 - Clin Cancer Res. 2004 Mar 15;10(6):1920-7
– reference: 24405573 - Breast Cancer Res. 2014 Jan 09;16(1):R2
– reference: 6571917 - J Natl Cancer Inst. 1983 Jan;70(1):27-30
– reference: 21805333 - J Mammary Gland Biol Neoplasia. 2011 Sep;16(3):221-33
– reference: 12942575 - Cancer. 2003 Sep 1;98(5):1055-60
– reference: 8562337 - Br J Cancer. 1996 Feb;73(3):323-6
– reference: 19127081 - Oncology. 2009;76(2):101-11
– reference: 17165440 - J Reprod Med. 2006 Nov;51(11):919-29
– reference: 9389532 - Endocrinology. 1997 Dec;138(12):5459-65
– reference: 23232806 - J Neurooncol. 2013 Feb;111(3):237-44
– reference: 18790764 - Mol Cancer Ther. 2008 Sep;7(9):2837-44
– reference: 8646523 - Ann Surg Oncol. 1996 Mar;3(2):204-11
– reference: 3994912 - Br J Cancer. 1985 May;51(5):691-7
– reference: 12816903 - Clin Chem. 2003 Jul;49(7):1074-80
– reference: 9891438 - Anticancer Res. 1998 Nov-Dec;18(6A):4003-10
– reference: 11368883 - Cancer Lett. 2001 Jul 10;168(1):93-100
– reference: 24596382 - Anticancer Res. 2014 Mar;34(3):1347-54
– reference: 22648499 - Nature. 2012 May 30;485(7400):S54
– reference: 10487517 - Mol Carcinog. 1999 Sep;26(1):10-9
– reference: 11326644 - Anticancer Res. 2000 Nov-Dec;20(6D):4949-51
– reference: 27152491 - Mol Carcinog. 2017 Feb;56(2):359-370
– reference: 9328178 - Carcinogenesis. 1997 Sep;18(9):1799-808
– reference: 16880503 - Glycobiology. 2006 Dec;16(12):1207-18
– reference: 20735820 - Reprod Biol Endocrinol. 2010 Aug 24;8:102
– reference: 15192308 - Tumour Biol. 2004 Jan-Apr;25(1-2):18-23
– reference: 10861507 - Int J Cancer. 2000 May 20;89(3):293-9
– reference: 5312521 - Bull World Health Organ. 1970;43(2):209-21
– reference: 10911614 - Mol Biotechnol. 2000 Jan;14 (1):47-57
– reference: 24556622 - Br J Cancer. 2014 Apr 2;110(7):1759-66
– reference: 2422163 - J Biol Chem. 1986 May 5;261(13):5907-16
– reference: 11870503 - Br J Cancer. 2002 Jan 21;86(2):185-9
– reference: 26495869 - Mol Endocrinol. 2015 Dec;29(12):1787-91
– reference: 11751407 - Cancer Res. 2001 Dec 15;61(24):8845-50
– reference: 25231360 - BMC Womens Health. 2014 Sep 18;14:113
– reference: 8655711 - J Clin Pathol. 1996 Apr;49(4):329-32
– reference: 25707740 - Placenta. 2015 Apr;36 Suppl 1:S60-5
– reference: 17302191 - Recent Results Cancer Res. 2007;174:111-30
– reference: 12679452 - J Clin Endocrinol Metab. 2003 Apr;88(4):1653-7
– reference: 27784743 - Cancer Res. 2017 Jan 1;77(1):134-141
– reference: 17139196 - Tumour Biol. 2007;28(1):52-6
– reference: 7351001 - Cancer. 1980 Jan 1;45(1):191-4
– reference: 15044447 - J Biol Chem. 2004 Jun 11;279(24):25503-10
– reference: 8900369 - Int J Cancer. 1996 Oct 21;69(5):369-74
– reference: 2328328 - Breast Cancer Res Treat. 1990 Jan;15(1):27-37
– reference: 15886246 - J Clin Endocrinol Metab. 2005 Aug;90(8):4873-9
– reference: 18339208 - Mol Cancer. 2008 Mar 14;7:26
– reference: 8062190 - Cancer. 1994 Sep 1;74(5):1591-4
– reference: 27529149 - Cancer Treat Rev. 2016 Sep;49:65-76
– reference: 25651787 - CA Cancer J Clin. 2015 Mar;65(2):87-108
– reference: 21997350 - Ann Surg Oncol. 2012 Apr;19(4):1167-73
– reference: 7538899 - Cancer Res. 1995 Jun 1;55(11):2257-61
– reference: 1917153 - Int J Cancer. 1991 Oct 21;49(4):526-30
– reference: 11895871 - Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):235-41
– reference: 26545404 - Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):60-7
– reference: 12114402 - Clin Cancer Res. 2002 Jul;8(7):2044-51
– reference: 14967177 - Clin Chim Acta. 2004 Mar;341(1-2):199-203
– reference: 2681548 - J Clin Epidemiol. 1989;42(10):963-73
– reference: 17510243 - Endocrinology. 2007 Aug;148(8):3694-703
– reference: 26504151 - Ann Oncol. 2015 Dec;26(12 ):2398-407
– reference: 22511284 - Int J Cancer. 2013 Jan 1;132(1):174-81
– reference: 22214378 - BMC Cancer. 2012 Jan 03;12:2
– reference: 25785349 - Breastfeed Med. 2015 Apr;10(3):175-82
– reference: 4044053 - Int J Cancer. 1985 Oct 15;36(4):427-32
– reference: 9012484 - Cancer Res. 1997 Feb 1;57(3):516-23
– reference: 24753159 - IUBMB Life. 2014 May;66(5):352-60
– reference: 6194155 - J Biol Chem. 1983 Oct 10;258(19):11492-9
– reference: 18936438 - Am J Epidemiol. 2008 Dec 1;168(11):1284-91
– reference: 25743784 - Hum Reprod. 2015 May;30(5):1029-38
– reference: 23424616 - PLoS One. 2013;8(2):e54592
– reference: 16464948 - J Clin Endocrinol Metab. 2006 Apr;91(4):1470-6
– reference: 21632857 - Clin Cancer Res. 2011 Jul 15;17(14):4844-53
– reference: 18758818 - J Cancer Res Clin Oncol. 2009 Feb;135(2):191-5
– reference: 27184120 - Sci Rep. 2016 May 17;6:25998
– reference: 14659129 - Breast. 2003 Dec;12(6):516-21
– reference: 2820711 - EMBO J. 1987 Jul;6(7):1899-904
– reference: 10789723 - Br J Cancer. 2000 May;82(9):1553-6
– reference: 16420967 - Vaccine. 2006 Mar 24;24(14):2575-84
– reference: 3237661 - Prev Med. 1988 Sep;17(5):634-42
– reference: 12756565 - Virchows Arch. 2003 Jul;443(1):44-50
– reference: 19204903 - Cancer. 2009 Mar 15;115(6):1174-84
– reference: 20713523 - Cancer Res. 2010 Sep 1;70(17):6779-86
– reference: 25448825 - Protein Expr Purif. 2015 Feb;106:10-7
– reference: 9150901 - Breast Cancer Res Treat. 1997 May;43(3):217-23
– reference: 11959894 - J Natl Cancer Inst. 2002 Apr 17;94(8):606-16
– reference: 16123088 - Hum Reprod. 2005 Dec;20(12):3360-8
– reference: 8004627 - Cancer. 1994 Jul 1;74(1 Suppl):518-27
– reference: 7911917 - Lancet. 1994 Jun 25;343(8913):1587-9
– reference: 18612147 - J Clin Oncol. 2008 Jul 10;26(20):3310-6
– reference: 15252849 - Int J Cancer. 2004 Sep 20;111(5):772-6
SSID ssj0023259
Score 2.3690145
SecondaryResourceType review_article
Snippet Breast cancer is well known as a malignancy being strongly influenced by female steroids. Pregnancy is a protective factor against breast cancer. Human...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1587
SubjectTerms Apoptosis
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Chorionic Gonadotropin - genetics
Chorionic Gonadotropin - metabolism
Chorionic Gonadotropin, beta Subunit, Human - genetics
Chorionic Gonadotropin, beta Subunit, Human - metabolism
Female
Genomic Imprinting
Health risk assessment
Hormone replacement therapy
Humans
Medical prognosis
Placenta - metabolism
Pregnancy
Review
Socioeconomic factors
Title Human Chorionic Gonadotropin and Breast Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/28754015
https://www.proquest.com/docview/2247771181
https://www.proquest.com/docview/1924599784
https://pubmed.ncbi.nlm.nih.gov/PMC5536074
Volume 18
WOSCitedRecordID wos000408746800253&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1422-0067
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0023259
  issn: 1422-0067
  databaseCode: 7X7
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1422-0067
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0023259
  issn: 1422-0067
  databaseCode: BENPR
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1422-0067
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0023259
  issn: 1422-0067
  databaseCode: PIMPY
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1422-0067
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0023259
  issn: 1422-0067
  databaseCode: M2O
  dateStart: 20000301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB3RLUhc-C4EShUkOKHQtR3b8QnRVQscuqwQSMspcvyhLoJs2WyR-PfMJNmwBcGFS5TIjmKN7bw39ngewFOEeBejsRn2qM9yiXeV9AaJXFTKcmE8j63YhJ5Oi_nczPoFt6YPq9z8E9sftV86WiM_RKjRWtMxyZfn3zJSjaLd1V5CYwd2KVNZPoLdo-Pp7P3gcgneyqUxRKFMSaO60HeBjv7h4vPXhhWIsJLC6bZB6Q-m-XvA5BYCndz837bfghs990xfdYPlNlwJ9R241qlR_rgLL9oF_XRyhq9Swtz0NbJ0dFpXdKYqtbVPjyiCfZ1OaKSs7sHHk-MPkzdZL6eQuZzxdcZ9oavgo3VRmsLqsUcAs9ExpngoxrmOVluLUMaFRJdZaRdMZZgIkliVFWIPRvWyDg8g5do7Q2IxQqqcRVmFsWOW60qyShinEni-sWfp-lzjJHnxpUSfg6xfbls_gWdD7fMux8Zf6u1vzFv2M60pf9k2gSdDMc4R2viwdVheNCU5mdKgv5wncL_ryeFD6DEiaWUyAX2pj4cKlH_7ckm9OGvzcEspFDKwh_9u1iO4zokKjHXG2T6M1quL8Biuuu_rRbM6gB091-21OOgHLz6d8nf4NHt7Ovv0Ex43-GA
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB1V2yK40PIdKBAkekKhsRPH8QEhWChdtV3toUjllDqOrS6CbNlsQf1T_Y3M5IstCG49cItkS7Ey4zfz4vE8gOcY4o1zSgdo0SKIBT7lolCYyLkk0TxSBXe12IQcj9OjIzVZgYvuLgyVVXaYWAN1MTP0j3wbQ42Ukq5Jvj79FpBqFJ2udhIajVvs2fMfSNmqV6N3aN8tznfeHw53g1ZVIDAx44uAF6nMbeG0cUKlWoYF4rh2hrGE2zSMpdNSa0R0Hglkjok0VuWKRVZQcqHpByhC_mqMzp4OYHUyOph86ilexGt5NoZRL0iESppS-yhS4fb089eKpRjRBZXvLQfBPzLb3ws0lyLezvr_9q024GabW_tvms1wC1ZseRuuNWqb53fgZX1g4Q9PcKnUENj_gCwESfmc7oz5uiz8t1Shv_CHtBPmd-HjlSz2HgzKWWkfgM9lYRSJ4UQiiZkTuQ0N01zmguWRMokHLzr7ZabtpU6SHl8y5FRk7WzZ2h5s9bNPmx4if5m32Zkza5Gkyn7Z0oNn_TBiAB3s6NLOzqqMSLRQSqaxB_cbz-lfhIwYk3ImPJCXfKqfQP3FL4-U05O6z7gQUYIZ5sN_L-spXN89PNjP9kfjvUdwg1PaE8qAs00YLOZn9jGsme-LaTV_0m4WH46v2ud-ApGQUB0
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5V5SEuvNsGCgSJnlDY2Int-IAQbFmoipYeQOotOI6tLoJsu9mC-tf4dczkxRYEtx64RbKlWJnxzPfF4_kAnmCKt95rE6FFyygV-FSIUiOQ81IanuiS-0ZsQk2n2eGhPliDH_1dGCqr7GNiE6jLuaV_5CNMNUopuiY58l1ZxMHu5MXxSUQKUnTS2stptC6y786-I32rn-_toq13OJ-8_jB-G3UKA5FNGV9GvMxU4UpvrBc6MyouMaYbbxmT3GVxqrxRxmB054lAFimVdbrQLHGCgIahn6EY_i-pFJMylQ3y9wPZS3gj1MYw_0VSaNkW3SeJjkezz19rlmFuF1TIt5oO_8C4v5dqruS-yY3_-avdhOsd4g5ftlvkFqy56jZcaTU4z-7As-YYIxwf4VKpTXD4BrkJUvUF3SQLTVWGr6hufxmOaX8s7sLHC1nsBqxX88ptQchVaTVJ5CRCpsyLwsWWGa4KwYpEWxnA096Wue06rJPQx5ccmRZZPl-1fAA7w-zjtrPIX-Zt96bNu_hS57_sGsDjYRgjAx33mMrNT-ucqLXQWmVpAJutFw0vQp6MUJ2JANQ5_xomUNfx8yPV7KjpPi5EIhF33vv3sh7BVXS0_N3edP8-XOOEhWIVcbYN68vFqXsAl-235axePGx2TQifLtrhfgJb1VdX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+Chorionic+Gonadotropin+and+Breast+Cancer&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Sch%C3%BCler-Toprak%2C+Susanne&rft.au=Treeck%2C+Oliver&rft.au=Ortmann%2C+Olaf&rft.date=2017-07-21&rft.pub=MDPI+AG&rft.issn=1661-6596&rft.eissn=1422-0067&rft.volume=18&rft.issue=7&rft_id=info:doi/10.3390%2Fijms18071587&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon